Virtus ETF Advisers’s Ambrx Biopharma Inc AMAM Stock Holding History

Virtus ETF Advisers’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-6,878	Closed	-$97.9K	–	494
2023 Q4	$97.9K	Buy	6,878 +85	+1%	+$966	0.06%	368
2023 Q3	$78.1K	Sell	6,793 -675	-9%	-$9.19K	0.05%	364
2023 Q2	$123K	Buy	+7,468	New	+$93.9K	0.07%	327

Virtus ETF Advisers's AMAM Position: Q1 2024 in Review

Virtus ETF Advisers sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 6,878 shares — an estimated $97.9K sold.

Virtus ETF Advisers first reported a position in AMAM in Q2 2023 and held it in 3 quarters. The position peaked at $123K in Q2 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

Virtus ETF Advisers reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
Virtus ETF Advisers sold 6,878 Ambrx Biopharma Inc shares in Q1 2024, an estimated $97.9K.
Virtus ETF Advisers first reported a position in Ambrx Biopharma Inc in Q2 2023 and held it in 3 quarters.
Virtus ETF Advisers's Ambrx Biopharma Inc position peaked at $123K in Q2 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Virtus ETF Advisers's 13F filing for Q1 2024, filed 15 May 2024.